On October 19, Biostock published an article on the development of advanced medical therapies in Sweden and how Sweden compares to an international comparison. The article mentions CombiGene together with other pharmaceutical companies such as AstraZeneca, Idogen, Xintela, Immunicum, NextCell Pharma and Verigraft.
The full article can be read here:
https://www.biostock.se/2020/10/msc-report-sweden-excels-within-cell-gene-therapy/